Empowered Funds’s Apellis Pharmaceuticals APLS Stock Holding History

Empowered Funds’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-148,038	Closed	-$5.96M	–	2122
2026 Q1	$5.96M	Buy	148,038 +134,657	+1,006%	+$2.9M	0.04%	570
2025 Q4	$336K	Buy	13,381 +40	+0.3%	+$938	0.01%	835
2025 Q3	$302K	Sell	13,341 -146	-1%	-$3.4K	﹤0.01%	1591
2025 Q2	$233K	Buy	+13,487	New	+$250K	﹤0.01%	1599

Other funds holding APLS

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Empowered Funds's APLS Position: Q2 2026 in Review

Empowered Funds sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 148,038 shares — an estimated $5.96M sold.

Empowered Funds first reported a position in APLS in Q2 2025 and held it in 4 quarters. The position peaked at $5.96M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Empowered Funds reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Empowered Funds sold 148,038 Apellis Pharmaceuticals shares in Q2 2026, an estimated $5.96M.
Empowered Funds first reported a position in Apellis Pharmaceuticals in Q2 2025 and held it in 4 quarters.
Empowered Funds's Apellis Pharmaceuticals position peaked at $5.96M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.